150 related articles for article (PubMed ID: 36252870)
1. Development and validation of a machine learning-based model for varices screening in compensated cirrhosis (CHESS2001): an international multicenter study.
Huang Y; Li J; Zheng T; Ji D; Wong YJ; You H; Gu Y; Li M; Zhao L; Li S; Geng S; Yang N; Chen G; Wang Y; Kumar M; Jindal A; Qin W; Chen Z; Xin Y; Jiang Z; Chi X; Cheng J; Zhang M; Liu H; Lu M; Li L; Zhang Y; Pu C; Ma D; He Q; Tang S; Wang C; Liu S; Wang J; Liu Y; Liu C; Liu H; Sarin SK; Xiaolong Qi
Gastrointest Endosc; 2023 Mar; 97(3):435-444.e2. PubMed ID: 36252870
[TBL] [Abstract][Full Text] [Related]
2. A combined model based on spleen stiffness measurement and Baveno VI criteria to rule out high-risk varices in advanced chronic liver disease.
Colecchia A; Ravaioli F; Marasco G; Colli A; Dajti E; Di Biase AR; Bacchi Reggiani ML; Berzigotti A; Pinzani M; Festi D
J Hepatol; 2018 Aug; 69(2):308-317. PubMed ID: 29729368
[TBL] [Abstract][Full Text] [Related]
3. A strategy for varices screening based on acoustic radiation force impulse combined with platelet (CHESS2001): An alternative of Baveno VI criteria.
Huang Y; Zhao L; He R; Li S; Liu C; Qi X; Li J
Hepatol Commun; 2022 Nov; 6(11):3154-3162. PubMed ID: 36121707
[TBL] [Abstract][Full Text] [Related]
4. Baveno VII algorithm outperformed other models in ruling out high-risk varices in individuals with HBV-related cirrhosis.
Zhang X; Song J; Zhang Y; Wen B; Dai L; Xi R; Wu Q; Li Y; Luo X; Lan X; He Q; Luo W; Lai Q; Ji Y; Zhou L; Qi T; Liu M; Zhou F; Wen W; Li H; Liu Z; Chen Y; Zhu Y; Li J; Huang J; Cheng X; Tu M; Hou J; Wang H; Chen J
J Hepatol; 2023 Mar; 78(3):574-583. PubMed ID: 36356684
[TBL] [Abstract][Full Text] [Related]
5. Validation of the Combined Model Based on Platelet Count and Albumin to Rule out High-Risk Varices in Liver Cirrhosis.
Duan Z; Li L; Li J; Zhou S
Biomed Res Int; 2020; 2020():5783748. PubMed ID: 32766309
[TBL] [Abstract][Full Text] [Related]
6. Modified and alternative Baveno VI criteria based on age for ruling out high-risk varices in patients with compensated cirrhosis.
Zhao L; Wang T; Guo C; Zhou L; Han P; Wang C; Ma Y; Wang J; Gao M; Li J
Hepatol Int; 2022 Aug; 16(4):936-943. PubMed ID: 35727500
[TBL] [Abstract][Full Text] [Related]
7. Prediction of Esophageal Varices by Liver Stiffness and Platelets in Persons With Human Immunodeficiency Virus Infection and Compensated Advanced Chronic Liver Disease.
Merchante N; Saroli Palumbo C; Mazzola G; Pineda JA; Téllez F; Rivero-Juárez A; Ríos-Villegas MJ; Maurice JB; Westbrook RH; Judge R; Guaraldi G; Schepis F; Perazzo H; Rockstroh J; Boesecke C; Klein MB; Cervo A; Ghali P; Wong P; Petta S; De Ledinghen V; Macías J; Sebastiani G
Clin Infect Dis; 2020 Dec; 71(11):2810-2817. PubMed ID: 31813962
[TBL] [Abstract][Full Text] [Related]
8. Spleen-dedicated stiffness measurement performed well to rule out high-risk varices in HBV-related hepatocellular carcinoma: Screening for high-risk varices in HCC.
Cheng X; Tang Y; He Q; Song J; Wang K; Li H; Huang J; Wang W; Li J; Wang H; Tu M; Chen J; Yuan G; Kang S; Liu H; Zhang X; Luo W; Ji Y; Lan X; Zhou L; Lai Q; Luo X; Wu Q; Zhou D; Tan Y; Chen J; Zhang X
Aliment Pharmacol Ther; 2024 Mar; 59(5):680-691. PubMed ID: 38155565
[TBL] [Abstract][Full Text] [Related]
9. Non-invasive prediction of esophageal varices by stiffness and platelet in non-alcoholic fatty liver disease cirrhosis.
Petta S; Sebastiani G; Bugianesi E; Viganò M; Wong VW; Berzigotti A; Fracanzani AL; Anstee QM; Marra F; Barbara M; Calvaruso V; Cammà C; Di Marco V; Craxì A; de Ledinghen V
J Hepatol; 2018 Oct; 69(4):878-885. PubMed ID: 29802949
[TBL] [Abstract][Full Text] [Related]
10. Quantification of liver extracellular volume using dual-energy CT for ruling out high-risk varices in cirrhosis.
Hong S; Kim JE; Cho JM; Choi HC; Won JH; Na JB; Choi DS; Park MJ; Choi HY; Shin HS; Cho HC; Kim HO
Eur J Radiol; 2022 Mar; 148():110151. PubMed ID: 35032849
[TBL] [Abstract][Full Text] [Related]
11. Machine Learning-based Development and Validation of a Scoring System for Screening High-Risk Esophageal Varices.
Dong TS; Kalani A; Aby ES; Le L; Luu K; Hauer M; Kamath R; Lindor KD; Tabibian JH
Clin Gastroenterol Hepatol; 2019 Aug; 17(9):1894-1901.e1. PubMed ID: 30708109
[TBL] [Abstract][Full Text] [Related]
12. Screening varices in patients with HBV-related cirrhosis on antiviral therapy: Platelet alone or together with LSM.
Wang B; Zhou J; Wu X; Sun Y; Li L; Li P; Li M; Jiang W; Xu M; Feng B; Xu X; Cheng J; Xie W; Han T; Wang X; Li H; Piao H; Wu S; Shi Y; Chen S; Kong Y; Ma H; Ou X; Jia J; You H
Liver Int; 2021 Feb; 41(2):369-377. PubMed ID: 33277803
[TBL] [Abstract][Full Text] [Related]
13. Application of Supersonic Shear Imaging to the Baveno VI Criteria and a Combination Model with Spleen Stiffness Measurement to Rule Out High-Risk Varices in Compensated Advanced Chronic Liver Disease.
Cho YS; Kim Y; Sohn JH
Ultraschall Med; 2022 Jun; 43(3):e13-e23. PubMed ID: 32434256
[TBL] [Abstract][Full Text] [Related]
14. Combined model with acoustic radiation force impulse to rule out high-risk varices in HBV-related cirrhosis with viral suppression.
Wang H; Xi R; Song J; Wen B; Zhang Y; Zhou L; Zhang X; Li Y; Zhou F; Zhu Y; Ji Y; Lai Q; He Q; Luo W; Qi T; Liu M; Lan X; Dai L; Chen J
Dig Liver Dis; 2023 Aug; 55(8):1062-1071. PubMed ID: 36863930
[TBL] [Abstract][Full Text] [Related]
15. Validating the BAVENO VI criteria to identify low risk biliary atresia patients without endoscopy for esophageal varix.
Kang Y; Park S; Kim S; Han SJ; Koh H
Clin Res Hepatol Gastroenterol; 2021 Jan; 45(1):101437. PubMed ID: 32417223
[TBL] [Abstract][Full Text] [Related]
16. Novel albumin, bilirubin and platelet criteria for the exclusion of high-risk varices in compensated advanced chronic liver disease: A validation study.
Wong YJ; Kew GS; Tan PS; Chen Z; Putera M; Yip WA; Ang TL; Fock KM; Lee GH; Hsiang J; Huang DQ; Kwek A; Muthiah MD; Kumar R; Tan M; Tan J; Thurairajah PH; Teo EK; Tai BC; Lim SG
Clin Res Hepatol Gastroenterol; 2021 Nov; 45(6):101598. PubMed ID: 33780835
[TBL] [Abstract][Full Text] [Related]
17. Baveno VI criteria and spleen stiffness measurement rule out high-risk varices in virally suppressed HBV-related cirrhosis.
Wang H; Wen B; Chang X; Wu Q; Wen W; Zhou F; Guo Y; Ji Y; Gu Y; Lai Q; He Q; Li J; Chen J; Hou J
J Hepatol; 2021 Mar; 74(3):584-592. PubMed ID: 33039403
[TBL] [Abstract][Full Text] [Related]
18. Extending and validating the Baveno VI criteria for the exclusion of high-risk varices.
Barbulescu A; Ratiu I; Sporea I; Lungeanu D; Lupusoru R; Miutescu B; Danila M; Popescu A; Sirli R
Med Ultrason; 2021 Aug; 23(3):265-270. PubMed ID: 33657192
[TBL] [Abstract][Full Text] [Related]
19. Validation of Baveno VI and Expanded-Baveno VI Criteria for predicting gastroesophageal varices in patients with alcoholic and non-alcoholic fatty liver disease.
Pizzamiglio M; Weicker A; de Terwangne C; Henrion J; Descamps OS; De Vos M
Acta Gastroenterol Belg; 2022; 85(2):321-329. PubMed ID: 35709776
[TBL] [Abstract][Full Text] [Related]
20. Use of biochemical parameters for non-invasive screening of oesophageal varices in comparison to elastography-based approach in patients with compensated advanced chronic liver disease.
Pastrovic F; Madir A; Podrug K; Lucijanic M; Bokun T; Zelenika M; Mustapic S; Unic A; Derek L; Grgurevic I
Biochem Med (Zagreb); 2022 Jun; 32(2):020712. PubMed ID: 35799983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
